| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1,2 M € | |||||||||||||||||||
| Gross margin | 162,3 k € | +12.1% | 144,7 k € | +377.9% | 30,3 k € | -72.4% | 109,8 k € | -20.0% | 137,2 k € | +31.2% | 104,6 k € | +62.2% | 64,5 k € | -17.6% | 78,3 k € | +72.2% | 45,5 k € | -80.1% | 228,2 k € | +4.6% | 218,1 k € | +11.5% | 195,5 k € | -25.2% | 261,5 k € | +67.9% | 155,8 k € | -23.1% | 202,5 k € | +5.6% | 191,7 k € | -21.2% | 243,2 k € | +18.8% | 204,7 k € | -7.1% | 220,4 k € | |
| EBITDA | 161,3 k € | +12.2% | 143,7 k € | +399.7% | 28,8 k € | -73.0% | 106,6 k € | -19.3% | 132,1 k € | +138.5% | 55,4 k € | -3.2% | 57,2 k € | +37.0% | 41,8 k € | +381.9% | -14,8 k € | -108.7% | 170,4 k € | +5.6% | 161,4 k € | +6.3% | 151,9 k € | -28.7% | 213,1 k € | +133.3% | 91,3 k € | -7.5% | 98,8 k € | +263.9% | 27,1 k € | -70.3% | 91,3 k € | +127.3% | 40,2 k € | -20.9% | 50,8 k € | |
| Operating profit | 91,2 k € | +24.3% | 73,4 k € | +265.4% | -44,4 k € | -237.9% | 32,2 k € | -44.4% | 57,9 k € | +854.0% | -7,7 k € | -114.4% | 53,2 k € | +32.0% | 40,3 k € | +343.9% | -16,5 k € | -109.8% | 168,8 k € | +5.6% | 159,8 k € | +24.7% | 128,2 k € | -32.5% | 189,9 k € | +178.7% | 68,1 k € | +50.5% | 45,3 k € | +265.7% | -27,3 k € | -171.3% | 38,3 k € | +402.3% | -12,7 k € | -308.9% | -3,1 k € | |
| Profit/loss | 51,0 k € | +8.7% | 46,9 k € | +199.7% | -47,0 k € | -281.8% | 25,9 k € | -38.4% | 42,0 k € | +233.0% | 12,6 k € | -80.7% | 65,4 k € | +11.8% | 58,5 k € | +173.5% | 21,4 k € | -84.9% | 141,5 k € | +0.1% | 141,4 k € | +18.6% | 119,2 k € | -26.1% | 161,3 k € | +140.8% | 67,0 k € | +7.7% | 62,2 k € | +554.5% | -13,7 k € | -152.7% | 25,9 k € | +237.8% | -18,8 k € | -126.3% | -8,3 k € | |
| Equity | 480,4 k € | +11.9% | 429,4 k € | +12.3% | 382,6 k € | -10.9% | 429,6 k € | +6.4% | 403,7 k € | +11.6% | 361,7 k € | +3.6% | 349,1 k € | +23.1% | 283,7 k € | +26.0% | 225,2 k € | +10.5% | 203,8 k € | +226.8% | 62,4 k € | -79.3% | 301,0 k € | +6.8% | 281,8 k € | +133.9% | 120,5 k € | +125.2% | 53,5 k € | +715.4% | -8,7 k € | -274.2% | 5,0 k € | +123.8% | -21,0 k € | -887.4% | -2,1 k € | |
| Total assets | 1,2 M € | -3.8% | 1,2 M € | -28.0% | 1,7 M € | -16.8% | 2,1 M € | -4.2% | 2,1 M € | +0.5% | 2,1 M € | +294.0% | 542,1 k € | +18.1% | 459,1 k € | +20.5% | 381,0 k € | -15.9% | 453,2 k € | -25.9% | 611,4 k € | -2.9% | 629,8 k € | +23.8% | 508,7 k € | +26.7% | 401,5 k € | -2.8% | 413,0 k € | -5.1% | 435,2 k € | +7.1% | 406,3 k € | -16.4% | 486,3 k € | -15.6% | 575,9 k € | |
| Cash | 11,3 k € | +880.6% | 1,2 k € | -99.2% | 153,4 k € | +102.1% | 75,9 k € | -44.4% | 136,5 k € | +73.9% | 78,5 k € | -63.2% | 213,4 k € | -0.1% | 213,6 k € | +62.1% | 131,8 k € | -48.9% | 258,0 k € | -38.9% | 422,6 k € | -3.3% | 437,1 k € | +49.6% | 292,2 k € | +107.2% | 141,0 k € | -4.3% | 147,4 k € | +16.1% | 126,9 k € | +490.6% | 21,5 k € | -68.3% | 67,9 k € | +572.7% | 10,1 k € | |
| Debts | 703,0 k € | -12.3% | 801,2 k € | -39.6% | 1,3 M € | -18.3% | 1,6 M € | -6.7% | 1,7 M € | -1.8% | 1,8 M € | +819.5% | 192,9 k € | +10.0% | 175,3 k € | +12.6% | 155,8 k € | -37.5% | 249,3 k € | -54.6% | 549,0 k € | +67.0% | 328,8 k € | +44.9% | 226,9 k € | -19.3% | 281,0 k € | -21.8% | 359,5 k € | -18.9% | 443,4 k € | +10.5% | 401,3 k € | -20.9% | 507,2 k € | -12.2% | 578,0 k € | |
| Staff | — | — | — | — | — | — | 0,3 | 0,8 | 1,3 | 1,1 | 1,3 | 1 | 1 | 1,4 | 2 | 2,8 | 3 | 3 | 3 | |||||||||||||||||||
Private limited company · Frameries · incorporated on 05/07/2006
Private limited company profitable and well capitalised. Cash position rising (+880.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
PHARMACIE ANDROMEDE is a Private limited company incorporated in 2006. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Frameries.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette